Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development. - Wikidata - awgldk - TriplyDB

Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.

Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.

http://www.wikidata.org/entity/Q42995350

about

Hepatitis C virus adaptation to T-cell immune pressure Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non genotype 1 infection A novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56+ cells for its action HCV genotype-3a T cell immunity: specificity, function and impact of therapy Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines.Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.Two successive hepatitis C virus infections in an intravenous drug user Regulation of cholangiocyte proliferation.Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection.Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection Immuno-informatics: Mining genomes for vaccine components.DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?Equivalent T cell epitope promiscuity in ecologically diverse human pathogens.Role of host genetic factors in the outcome of hepatitis C virus infection.Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis.Vaccination with dendritic cells pulsed with hepatitis C pseudo particles induces specific immune responses in mice.Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus Glances in Immunology of HIV and HCV Infection Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis.Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection.TH1 cytokine response to HCV peptides in Egyptian health care workers: a pilot study.CD4+ T cell responses in hepatitis C virus infection.High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome.Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection.Definition of CD4 Immunosignatures Associated with MTB.T cell responses to viral infections - opportunities for Peptide vaccination.Interaction of allergens, major histocompatibility complex molecules, and T cell receptors: a 'ménage à trois' that opens new avenues for therapeutic intervention in type I allergy.Host genetics in immune-mediated hepatitis C virus clearance.Antigens for CD4 and CD8 T cells in tuberculosis.Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.Sarcoidosis with Both Plaques and Subcutaneous Nodules Associated with Combination Therapy with Peginterferon α-2a and Ribavirin Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection.Immune responses in hepatitis C virus infection: the role of dendritic cells.

P2860

Q26862729-997042C4-551D-4BE2-9050-790F2DD3EA1E Q27471458-C47DCB09-4078-4B60-9824-A01CA2205DDA Q27472915-BF8EF731-0CF4-4296-BE87-E02322F2D053 Q27478105-C9B1253A-5DCF-46B7-88EC-403C5A1F7496 Q27480953-EA0CDEAD-F968-4CB9-956B-5B05CABC40DE Q27481055-1EE8D618-F4EE-42D6-A294-DDCFA542EF95 Q27486084-B74F2BD8-8E67-42FB-A4EA-4DF575E2E0C1 Q28687729-BE6D7BFD-62EC-4B94-9BD7-F8FF10D23F1F Q30532816-0655ACBC-C0D9-49F7-A43B-54E7BD626CDE Q33300465-C1FB834D-E077-4A6C-A47C-E2C5778CF776 Q33530024-627FC095-7C9B-49F9-9442-14DCBD31B005 Q33969003-30F20091-9ABE-44F7-8A3E-BA8DD59FAB39 Q34229378-4FD3241D-A9B6-4908-9C84-040DAE6CA77E Q34294938-81E0092B-F4F1-421C-95A9-BED5D741223C Q34642558-131FA528-7AAE-449E-877E-5665C8323947 Q34687622-8939DDF3-E3BB-4EA8-B706-99E7AE207C0F Q34812028-3F14B037-7F93-4537-A5EC-06EBE4369E82 Q34951888-FB7542F3-E7D8-4A88-AA48-C535D81B7153 Q35259735-DDAC0B17-65A1-47F5-B227-3F639E746BC9 Q35613902-602056E7-E42E-4A0F-A615-AD574794269F Q35776114-EA137407-E664-48B3-A471-10B7B929B715 Q35784239-8C3BB88A-CB82-4935-A1D5-0A2C0C8BC7D8 Q36032051-10BEF4AF-ED34-402C-8641-89CF37C81423 Q36497084-C1B1FB08-30A1-4469-9C39-F8008006D1BA Q36666331-2A4D1313-04C2-474E-9C1E-5730ACF92652 Q36849397-75F3D573-3EB3-47F1-B96F-61CC6BE29E81 Q36935527-BB33E442-CF63-44CC-A221-1A1527B1C709 Q36978998-D1B4B38E-DE90-4553-9024-BFC1CB015F7D Q37583435-FD3EDBDE-840E-48F8-81A1-03819A43EED7 Q37672921-08A21031-39BA-4695-9658-84311E304549 Q37718978-73A7DB34-63F0-4AED-B020-E0E13DACCA40 Q37859218-E85ED4D4-8E32-477A-96CE-6A7D3C7B8F7D Q37862746-1CE0C3FB-D685-4916-AB5B-38951EE5BD3C Q38213801-60C35F44-E3E5-4D4A-A144-48180808AB78 Q40761226-6318995B-60E2-4EA0-942F-17CFEE05D081 Q41648212-4BA5644E-60DB-48FD-AB9B-BF6390E3491D Q41833583-562C7A15-6F8A-4DA8-9F0B-2FE88212F0C4 Q42997235-8CC965D8-B26E-48EA-9648-1262F11AB860 Q43031795-0DF9EAE5-7A99-488D-874E-3E0BF23F4BA9 Q43041887-B14052C7-79ED-402E-877F-9753BADB3B68

P2860

Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.

http://www.wikidata.org/entity/Q42995350

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Conserved hepatitis C virus sequences are highly immunogenic for CD4

@nl

Conserved hepatitis C virus se ...... tions for vaccine development.

@en

type

label

Conserved hepatitis C virus sequences are highly immunogenic for CD4

@nl

Conserved hepatitis C virus se ...... tions for vaccine development.

@en

prefLabel

Conserved hepatitis C virus sequences are highly immunogenic for CD4

@nl

Conserved hepatitis C virus se ...... tions for vaccine development.

@en

P1433

Q42995350-B6565B98-D245-4157-9A7D-0999EBE7DE1E

P1476

Q42995350-677D8824-DD60-419D-8115-76E80AF77925

P2093

Q42995350-20356C6E-C30A-48D8-80E8-08E9189B7F49

Q42995350-4D87845B-2E4C-4246-9D41-86FA6DFEEBFC

Q42995350-95DCB4C2-9B1C-45AD-86BA-0709F3F391AB

Q42995350-B7BEF09A-9A7D-439A-B7E0-E5BF46C181C7

Q42995350-BB670A87-8F0C-492D-9A0F-54D1BFFCA6F9

Q42995350-BB9D6467-8FF9-49AB-A1A4-062D4F44E416

Q42995350-BD1172F2-51C5-4685-87BA-870A6225C291

Q42995350-E10F6CD5-1C6A-47A3-9D8E-2FEC8391939C

Q42995350-E3DC7215-0D00-4776-8414-C6CB15090495

Q42995350-EB42F346-2AF2-466C-B7CF-FB5D76FB1883

P304

Q42995350-73B09E51-CF24-42EE-B107-02E3B0D406ED

P31

Q42995350-734FF40E-8E12-4F25-9E8B-5435EEF210F9

P356

Q42995350-2B129403-28B4-467E-859A-BF9AF77F1D27

P407

Q42995350-C6704FF1-756E-4F65-826D-0A3D99508DC1

P433

Q42995350-84E080D9-522B-43CF-B559-7DFE06D8DDF1

P478

Q42995350-0149127F-5639-49E9-9DC3-C8809AC2FFD7

P50

Q42995350-0C2470A2-AB94-4F92-8B8F-75FA797A33D8

Q42995350-58069717-74F2-491E-B875-8101C1BE7B84

Q42995350-D1312C9A-0E15-458D-982C-483CAF3B644C

Q42995350-E87E517B-0490-4BE0-9EE2-ADFB888779FC

P577

Q42995350-32AC4551-5A42-4F47-9D85-6D2A82A9111A

P5875

Q42995350-002A843B-41E5-46B2-A1C8-02FCE4F38938

P698

Q42995350-7A19CFED-A725-401D-BEB3-7D7B2D2B7E04

P356

P1433

P1476

Conserved hepatitis C virus se ...... ations for vaccine development

@en

P2093

Bertoni R

http://www.w3.org/2001/XMLSchema#string

Fiaccadori F

http://www.w3.org/2001/XMLSchema#string

Lamonaca V

http://www.w3.org/2001/XMLSchema#string

Massari M

http://www.w3.org/2001/XMLSchema#string

Mori C

http://www.w3.org/2001/XMLSchema#string

Pilli M

http://www.w3.org/2001/XMLSchema#string

Sette A

http://www.w3.org/2001/XMLSchema#string

Southwood S

http://www.w3.org/2001/XMLSchema#string

Urbani S

http://www.w3.org/2001/XMLSchema#string

Valli A

http://www.w3.org/2001/XMLSchema#string

P304

1088-1098

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.510300435

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Gabriele Missale

P577

1999-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12801034

http://www.w3.org/2001/XMLSchema#string

P698

10498664

http://www.w3.org/2001/XMLSchema#string